Large between-patient variability in egfr decline before clinical trial enrollment and impact on atrasentan’s efficacy: a post hoc analysis from the SONAR trial

  1. Waijer, S.W.
  2. de Vries, S.T.
  3. Busch, R.
  4. Xie, D.
  5. Gansevoort, R.T.
  6. Hou, F.F.
  7. Gorriz, J.L.
  8. Laverman, G.D.
  9. de Nicola, L.
  10. Pascual, J.
  11. Provenzano, M.
  12. Pergola, P.E.
  13. Tang, S.C.W.
  14. Wanner, C.
  15. Zaoui, P.
  16. Parving, H.-H.
  17. de Zeeuw, D.
  18. Heerspink, H.J.L.
Aldizkaria:
Journal of the American Society of Nephrology

ISSN: 1533-3450,  1046-6673

Argitalpen urtea: 2021

Alea: 32

Zenbakia: 11

Orrialdeak: 2731-2734

Mota: Artikulua

DOI: 10.1681/ASN.2021040498 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus